Mizushima Y, Hamano T, Haramoto S, Kiyokawa S, Yanagawa A, Nakura K, Shintome M, Watanabe M
Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan.
Prostaglandins Leukot Essent Fatty Acids. 1990 Dec;41(4):269-72. doi: 10.1016/0952-3278(90)90141-7.
The intravascular distribution of 0.2 mu lipid microspheres (LM) containing prostaglandin E1 (lipo-PGE1) injected intravenously in spontaneously hypertensive rats (SHR) and arteriosclerotic rabbits was investigated by electron microscopic observation and quantification of radiolabelled compounds. LM were observed under an electron microscope to concentrate in subendothelial space of vascular walls, particularly in vascular lesions associated with hypertension or arteriosclerosis. Radiolabelled lipo-PGE1 accumulated more densely in the vascular walls than did free PGE1, and the difference was more conspicuous in vascular lesions. This indicates that lipo-PGE1 penetrates vascular endothelium and then accumulates in blood vessels to result in augmentation of the pharmacological action of prostaglandin. These findings suggest the usefulness of LM as a carrier of prostaglandin to vascular lesions.
通过电子显微镜观察和放射性标记化合物的定量分析,研究了静脉注射含前列腺素E1的0.2微米脂质微球(lipo - PGE1)在自发性高血压大鼠(SHR)和动脉粥样硬化兔体内的血管内分布情况。在电子显微镜下观察到脂质微球集中在血管壁的内皮下间隙,尤其是在与高血压或动脉粥样硬化相关的血管病变处。放射性标记的lipo - PGE1在血管壁中的积累比游离前列腺素E1更密集,且这种差异在血管病变处更为明显。这表明lipo - PGE1穿透血管内皮,然后在血管中积累,从而增强前列腺素的药理作用。这些发现提示脂质微球作为前列腺素向血管病变部位递送载体的有用性。